Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
SciSparc Ltd a specialty clinicalstage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system announced today that it signed a merger agreement with AutoMax Motors Ltd a lead...
Gennao Bio a privately held genetic medicines company developing firstinclass targeted nucleic acid therapeutics today announced new preclinical results on the application of its nonviral cell penetrating
BioCity Biopharma today announced that the US Food and Drug Administration has cleared the companys Investigational New Drug application for a Phase study of BC BC which is BioCitys second
The World Orphan Drug Alliance a global alliance of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in complex markets around the world
CorMedix Inc a biopharmaceutical company focused on developing therapeutic products for lifethreatening diseases and conditions today announced that it has entered into a year commercial supply contract with Floridabased dialysis provider ARC Dialysi...
Starpharma today announces it has entered into a strategic partnership with Medicxi a leading life sciences investment firm dedicated to financing companies developing
Renalys Pharma Inc announced that it has submitted an Investigational New Drug Application for sparsentan to the Pharmaceuticals and Medical Devices Agency for a Phase III clinical trial in Japan
Eilean Therapeutics LLC a biopharmaceutical company dedicated to discovering and developing bestinclass and firstinclass small molecule inhibitors to target escape mutations in hematologic
Teva Pharmaceuticals International GmbH a subsidiary of Teva Pharmaceutical Industries Ltd and mAbxience a Fresenius Kabi majorityowned group with partial ownership from Insud Pharma today
Biognosys a global leader in mass spectrometrybased proteomics and Alamar Biosciences Inc a company powering precision proteomics to enable the earliest detection of disease are pleased
